文献速递心境障碍

双相障碍首次发作维持剂量与再入院风险关联

Association between maintenance doses of mood stabilizers and antipsychotics and risk of readmission in first-episode bipolar disorder.
PubMed 文献 · Mol Psychiatry · 2026-07-31

该研究基于韩国国民健康保险数据库,纳入2002至2022年间19-60岁首次因双相障碍住院的患者,评估维持期心境稳定剂与抗精神病药剂量与再入院风险的关系。研究发现,心境稳定剂剂量低于0.4 DDD/天或急性期剂量的80%、抗精神病药低于0.5 DDD/天或50%时,再入院风险增加,且一种药物低剂量时另一种药物高于阈值可减弱风险。

要点

  • 心境稳定剂维持剂量低于0.4 DDD/天或急性期80%时再入院风险增加。
  • 抗精神病药维持剂量低于0.5 DDD/天或急性期50%时再入院风险增加。
  • 一种药物低剂量时,另一种高于阈值可减弱再入院风险。

核心结论

  • 首次发作双相障碍患者维持期心境稳定剂或抗精神病药剂量低于特定水平与再入院风险增加相关。

研究设计与样本

  • 基于韩国国民健康保险数据库的回顾性队列研究,纳入2002至2022年19-60岁首次因双相障碍住院患者。
  • 出院后随访期间评估维持剂量为绝对剂量(DDD/天)和相对剂量(急性期剂量的百分比)。
  • 采用时依Cox回归估计再入院风险比(HR)及95%置信区间(CI)。

主要发现

  • 心境稳定剂剂量低于0.4 DDD/天(绝对)和80%(相对)时,连续和分类分析均显示剂量与再入院呈负剂量反应关系。
  • 抗精神病药剂量低于0.5 DDD/天和50%时再入院风险逐步升高,高于这些水平后趋于平台。
  • 联合剂量分类分析提示,一种药物低剂量相关的再入院风险增加在另一种药物高于观察阈值时减弱。
  • 时间分层分析中,上述关联在随访三年后显著。

关键数值与推荐

  • 心境稳定剂绝对剂量阈值0.4 DDD/天,相对剂量阈值80%。
  • 抗精神病药绝对剂量阈值0.5 DDD/天,相对剂量阈值50%。
  • 上述阈值基于时依Cox回归的再入院风险估计。

临床怎么用

  • 临床减量时需谨慎,避免心境稳定剂低于0.4 DDD/天或急性期80%、抗精神病药低于0.5 DDD/天或50%。
  • 若一种药物减至低剂量,可考虑维持另一种药物高于相应阈值以降低再入院风险。
  • 随访三年后尤其关注剂量与再入院风险的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Physicians aim to identify the lowest effective dose for maintenance pharmacotherapy in bipolar disorder, but evidence remains limited. We aimed to investigate the association between maintenance doses of mood stabilizers and antipsychotics and relapse risk in patients with first-episode bipolar disorder. Using the Korean National Health Insurance Database, we identified patients aged 19-60 years with a first admission for bipolar disorder between 2002 and 2022. After discharge from the first admission (acute phase), maintenance doses of mood stabilizers and antipsychotics were assessed as absolute doses (defined daily doses [DDDs]/day) and relative doses (percentages of the acute-phase dose) during follow-up. The outcome was readmission for mood disorders. Hazard ratios (HRs) and 95% confidence intervals (CIs) for readmission according to time-varying maintenance doses were estimated using time-dependent Cox regression. A negative dose-response relationship between mood stabilizer dose and readmission was observed below 0.4 DDDs/day (absolute) and 80% (relative) in both the continuous and categorical analyses. For antipsychotics, a progressively higher risk of readmission was observed below 0.5 DDDs/day and 50%, with a near plateau above these levels. Joint dose-category analyses suggested that increased readmission risk associated with low-dose mood stabilizers or antipsychotics was attenuated when the other class was used above the observed dose threshold. In time-stratified analyses, these associations were significant after three years of follow-up. This study found that maintenance doses of mood stabilizers and antipsychotics below specific levels were associated with increased readmission risk in first-episode bipolar disorder, which may help inform clinically cautious dose reduction strategies.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Kang S, Baek JH, Kim SJ, et al. Association between maintenance doses of mood stabilizers and antipsychotics and risk of readmission in first-episode bipolar disorder. Mol Psychiatry. 2026. PMID: 42538393. doi:10.1038/s41380-026-03782-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。